NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) – Equities researchers at Zacks Small Cap issued their Q1 2024 earnings estimates for NeuroBo Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.95) per share for the quarter. The consensus estimate for NeuroBo Pharmaceuticals’ […]
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Free Report)’s share price traded down 1.2% during trading on Monday . The stock traded as low as $0.43 and last traded at $0.45. 123,703 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 574,195 shares. The stock had previously closed at […]
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, […]
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) saw a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, the days-to-cover ratio […]
Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Rating) were up 1.1% on Friday . The company traded as high as $0.51 and last traded at $0.50. Approximately 88,557 shares changed hands during trading, a decline of 87% from the average daily volume of 680,821 shares. The stock had previously closed at $0.50. NeuroBo Pharmaceuticals […]